AxoGen (NASDAQ:AXGN - Get Free Report) released its quarterly earnings data on Tuesday. The medical equipment provider reported $0.07 EPS for the quarter, missing analysts' consensus estimates of...
MarketBeat·2d ago
More News
AxoGen (NASDAQ:AXGN) Price Target Raised to $48.00 at Wells Fargo & Company
Wells Fargo & Company increased their price target on AxoGen from $40.00 to $48.00 and gave the company an "overweight" rating in a report on Wednesday...
MarketBeat·2d ago
AxoGen (NASDAQ:AXGN) Price Target Raised to $50.00
Citizens Jmp raised their price target on shares of AxoGen from $42.00 to $50.00 and gave the company a "market outperform" rating in a research report on Wednesday...
MarketBeat·2d ago
AxoGen (NASDAQ:AXGN) Hits New 1-Year High - Here's Why
AxoGen (NASDAQ:AXGN) Sets New 12-Month High - Here's Why...
MarketBeat·3d ago
AxoGen Q1 Earnings Call Highlights
AxoGen (NASDAQ:AXGN) reported first-quarter 2026 revenue of $61.5 million, up 26.6% year over year, as management pointed to broad-based growth across its target markets and continued adoption of its...
MarketBeat·3d ago
CommVault, Kforce, AxoGen And Other Big Stocks Moving Higher On Tuesday
U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimates. Other gainers include Kforce, Omnicell, and AxoGen.read more...
Benzinga·3d ago
AxoGen (AXGN) Q1 Earnings Lag Estimates
AxoGen (AXGN) delivered earnings and revenue surprises of -41.67% and +4.70%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million
Key PointsAcquired 687,600 shares of Axogen; estimated trade size of $22.36 million based on quarterly average pricing...
Nasdaq News: Markets·5d ago
B. Metzler seel. Sohn & Co. AG Takes $1.95 Million Position in AxoGen, Inc. $AXGN
B. Metzler seel. Sohn & Co. AG acquired a new stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) during the 4th quarter, according to the company in its most recent filing with the...
MarketBeat·6d ago
Lake Street Capital Boosts AxoGen (NASDAQ:AXGN) Price Target to $50.00
Lake Street Capital raised their price objective on AxoGen from $40.00 to $50.00 and gave the company a "buy" rating in a research report on Thursday...